Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

But new research suggests these drugs could be doing more than helping people shed pounds. Scientists at the University of Bern in Switzerland have discovered a side effect no one expected. Presented ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more effective than rival Wegovy.

After nearly 18 years on medication to manage her high blood pressure, Charity Wischmeyer, 51, is now discussing with her ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Q. I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were ...

The global market for Ozempic, Wegovy and similar drugs is projected to explode during the next five years. Fashion - which ...

Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...